News
14d
Inquirer Opinion on MSNMpox impactsOver dinner with my family, I casually asked if they were aware of monkeypox or mpox. They responded in the affirmative and ...
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.
The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...
The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...
5don MSN
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
Learning the best type of HIV prevention for those at highest risk can start with conversations about their options, writes ...
Experts said a successful launch of a long-acting HIV prevention drug could help stall the epidemic. Until recently, the only pre-exposure prophylaxis (PrEP) options for people at high risk of ...
“These grants support vital public health initiatives, including childhood immunizations, infectious disease control, mental health programs, and HIV prevention and treatment,” Central Florida Rep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results